Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients

By Kim W.   Lee S.   Kang S.K.   Yu H.C.   Cho B.H.   Park S.K.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3223-3224

Elsevier

Access to resources Recommend Favorite

Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor-Deficient Mice

By Levy Z.  

International Journal of Experimental Diabetes Research, Vol. 4, Iss. 1, 2003-01 ,pp. : 59-64

Informa Healthcare

Access to resources Recommend Favorite

The Relationship Between Hypertensive Retinopathy and Angiotensin Converting Enzyme Gene Polymorphism

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 57-61

Bentham Science Publishers

Access to resources Recommend Favorite

Congenic Spontaneously Diabetic Hypertensive BB.SHR Rats

By Voigt B.   Berg S.   Kovacs P.   Vogt L.   Kloting I.  

Transplantation Proceedings, Vol. 29, Iss. 3, 1997-05 ,pp. : 1677-1678

Elsevier

Access to resources Recommend Favorite

IL-2 receptor blockers in liver transplantation: initial experience with daclizumab in Chile

By Innocenti F.   Humeres R.   Zamboni M.   Sanhueza E.   Zapata R.   Hepp J.   Rius M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2520-2521

Elsevier

Access to resources Recommend Favorite